Company intelligence / Profile preview

Ceevra

San Francisco, California, United Statesceevra.com ↗

Ownership: Private
Development stage: Commercial

Overview

Ceevra’s AI-powered software generates patient-specific interactive 3D models from CTs and MRIs to aid in surgical planning. Clinical trials have shown that use of these models improves patient outcomes in robotic prostatectomy and partial nephrectomy procedures. The product has received FDA 510(k) clearance as well as EU MDR certification.

Therapeutic areas: OtherNephrologyMen's Health
Modalities: Device (software)Non-pharmacological therapy (digital surgical planning)
Industry: Medical Imaging

Partnerships

Leading academic medical centers; two of the ten largest US health systems are customers/partners.

Beyond the preview

Go deeper on Ceevra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceevra.

Explore the full profile